# Perindopril Amlodipine for the Treatment of Hypertension

> **NCT01556997** · PHASE3 · COMPLETED · sponsor: **Symplmed Pharmaceuticals LLC** · enrollment: 837 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** XOMA 985
- **DRUG:** Amlodipine Besylate
- **DRUG:** Perindopril Erbumine

## Key facts

- **NCT ID:** NCT01556997
- **Lead sponsor:** Symplmed Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 837 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01556997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01556997, "Perindopril Amlodipine for the Treatment of Hypertension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01556997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*